Success Metrics

Clinical Success Rate
92.3%

Based on 48 completed trials

Completion Rate
92%(48/52)
Active Trials
8(11%)
Results Posted
33%(16 trials)
Terminated
4(6%)

Phase Distribution

Ph not_applicable
27
39%
Ph early_phase_1
1
1%
Ph phase_1
2
3%
Ph phase_2
9
13%
Ph phase_3
14
20%
Ph phase_4
15
21%

Phase Distribution

3

Early Stage

9

Mid Stage

29

Late Stage

Phase Distribution68 total trials
Early Phase 1First-in-human
1(1.5%)
Phase 1Safety & dosage
2(2.9%)
Phase 2Efficacy & side effects
9(13.2%)
Phase 3Large-scale testing
14(20.6%)
Phase 4Post-market surveillance
15(22.1%)
N/ANon-phased studies
27(39.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

48 of 56 finished

Non-Completion Rate

14.3%

8 ended early

Currently Active

8

trials recruiting

Total Trials

70

all time

Status Distribution
Active(11)
Completed(48)
Terminated(8)
Other(3)

Detailed Status

Completed48
Recruiting8
Withdrawn4
Terminated4
Not yet recruiting3
unknown3

Development Timeline

Analytics

Development Status

Total Trials
70
Active
8
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.5%)
Phase 12 (2.9%)
Phase 29 (13.2%)
Phase 314 (20.6%)
Phase 415 (22.1%)
N/A27 (39.7%)

Trials by Status

withdrawn46%
completed4869%
not_yet_recruiting34%
terminated46%
recruiting811%
unknown34%

Recent Activity

Clinical Trials (70)

Showing 20 of 70 trialsScroll for more
NCT06884280Phase 3

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Recruiting
NCT07061470Phase 1

A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep

Not Yet Recruiting
NCT07081152Not Applicable

Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity

Recruiting
NCT07414199Phase 4

The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department

Not Yet Recruiting
NCT07340450Not Applicable

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

Completed
NCT03817957Phase 3

Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency

Completed
NCT04278651Phase 4

Early Antenatal Support for Iron Deficiency Anemia

Recruiting
NCT05126901Phase 3

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Completed
NCT01481766Not Applicable

Iron Treatment for Young Children With Non-anemic Iron Deficiency

Completed
NCT04144790

Impact of Iron Supplementation Treatment on Brain Iron Concentrations

Completed
NCT04253626Phase 3

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Completed
NCT03991169Phase 4

Oral Iron in Children With Chronic Kidney Disease

Recruiting
NCT07053475Phase 4

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Recruiting
NCT05462704Phase 3

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Recruiting
NCT03212677Not Applicable

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

Completed
NCT06742528Not Applicable

Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients

Recruiting
NCT05423249Not Applicable

Treatment of Non-Anemic Iron Deficiency in Pregnancy

Completed
NCT02839096Not Applicable

Once Versus Twice Daily Iron Supplementation in Pregnant Women

Terminated
NCT04087993Phase 3

Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

Withdrawn
NCT06521216

Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
70